相关实验视频
Updated: Jul 27, 2025

07:22
Creation of Colonic Anastomosis in Mice
Published on: January 17, 2019
11.7K
解剖口腔:当前对病原和管理的理解
Shaunte McKay1, Valeria Cohran1, Lee M Bass2
1Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, 225 E. Chicago Ave Box #65, Chicago, IL, 60611, USA.
Current gastroenterology reports
|June 11, 2023
概括
肠道手术后的解剖口腔可能会导致儿童严重贫血. 通过内镜进行早期诊断和治疗,包括药物或手术,对于管理这种情况至关重要.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 外科胃肠道外科手术
- 血液学 血液学 血液学
背景情况:
- 肠切除后的静脉是儿科患者中未被认可的并发症.
- 这种情况可能导致严重的健康问题,包括耐火性贫血.
研究的目的:
- 在肠切除后对儿科解剖口腔的文献进行审查.
- 为突出这种情况的诊断和治疗方法.
主要方法:
- 在小儿病患者中对静脉性的文献综述.
- 讨论诊断方式,如上下内镜和小肠内镜.
- 治疗策略的概述,包括医疗和手术选择.
主要成果:
- 解肠是儿童肠切除后耐火性贫血的一个重要原因.
- 评估需要解决微量营养素缺陷和全面的内镜评估.
- 医学治疗包括抗炎药物和抗生素用于小肠细菌的过度生长.
- 对于那些不耐医疗治疗的病例,考虑进行手术切除.
结论:
- 在小肠切除后出现不明原因的缺铁性贫血的情况下,应考虑小儿解剖性.
- 及时内镜评估对于诊断至关重要.
- 如果医疗管理未能解决,可能需要手术干预.
相关概念视频
Peptic Ulcer Disease V: Surgical Management and Nursing Care
349
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
349
Peptic Ulcer Disease IV: Management
115
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
115
Peptic Ulcer Disease II: Pathophysiology
575
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
575
Inflammatory Bowel Disease V: Surgical Management
174
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
174
Peptic Ulcer Disease I: Introduction
217
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
217
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
472
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
472

